102 Compounds.
One Sentence.
That Is the Problem.
The most pharmacologically sophisticated women’s herb in the Malaysian rainforest — reduced to a postpartum label
Kacip Fatimah has documented vasorelaxant effects on hypertensive blood vessels. It maintained arterial wall architecture comparable to non-operated rats in direct aorta studies. It suppressed tumour-feeding blood vessel growth through VEGF downregulation. And the supplement industry never mentions any of it — because the marketing stopped at “women’s herb.”
What Happens When a Plant’s Cardiovascular Research Gets Buried Under Its Marketing
A study published in PMC (2021) tested the water fraction of Labisia pumila on spontaneously hypertensive rat aortic ring preparations — the same experimental framework used to evaluate pharmaceutical antihypertensives. The result was significant vasorelaxation through endothelium-dependent mechanisms.
The biomarker compounds responsible: gallic acid and catechin — both present in the water extract, both documented antihypertensives. The mechanisms: nitric oxide production and calcium channel modulation — precisely the pathways targeted by pharmaceutical blood pressure medications.
A separate aorta study found that Kacip Fatimah water extract maintained the elastic lamellae architecture of arterial walls in ovariectomised rats at a level comparable to non-operated normal rats. The elastic lamellae are what give arteries their ability to expand and recoil with each heartbeat. When they degrade — with oestrogen loss, chronic inflammation, and age — arterial walls stiffen and blood pressure rises. Maintaining this architecture is a fundamental mechanism of cardiovascular protection.
The supplement labels say: “Women’s vitality. Postpartum recovery. Hormonal balance.”
The research says: cardiovascular protection mechanisms that pharmaceutical companies spend billions researching.
The wrong default is a marketing decision, not an evidence decision.
What the Evidence Actually Shows
2025 comprehensive PubMed review. Flavonoids, phenolic acids, saponins, phytoestrogens, benzoquinones, alkyls. A matrix — not a single active ingredient.
Postmenopausal. 280mg/day water extract. Result: significantly lower triglycerides in treatment group vs placebo (1.4 vs 1.9 mmol/L).
Dr. Hawa ZE Jaafar’s CO₂ enrichment cultivation technique increases phytochemical concentration by 180–1,000% while reducing harvest time from 16–18 months to 7–8 months.
Burkill, 1935. The traditional use his documentation recorded already reflected generations of empirical observation by Malay and Orang Asli communities.
IMR Malaysia (2002) documented both estrogenic and androgenic activities. The marketing is gendered. The plant is not.
Significant suppression of microvessel outgrowth via VEGF downregulation — the protein tumours require to form new blood vessels for growth.
Five Things That Reframe This Plant
The cardiovascular research uses the same experimental framework as pharmaceutical antihypertensive drug testing — and the results are significant.
Spontaneously hypertensive rat aortic ring preparations are the gold standard pre-clinical model for blood pressure medications. Kacip Fatimah water extract produced significant vasorelaxation in this model. Gallic acid and catechin — identified as the biomarker compounds — are both documented antihypertensives.
The IMR documented both estrogenic AND androgenic activities. This plant is not a women’s herb — it is a hormonal regulator.
Malaysia’s Institute for Medical Research (2002) confirmed both activities in the same plant. Phytoestrogens bind to estrogen receptors with significantly lower affinity than human estrogen — modulating rather than replacing. In deficiency: compensatory. In adequacy: non-additive.
102 identified compounds means the whole plant behaves differently from any extract. The traditional concoction is not superstition — it is pharmacology.
The gallic acid and catechin responsible for vasorelaxation are found in the water fraction — the traditional decoction. Many commercial capsules use non-water extraction methods that may not capture these compounds in the same form or concentration. The traditional preparation method is pharmacologically precise.
VEGF suppression puts Kacip Fatimah in the category of plants actively researched as chemotherapy adjuncts — not wellness herbs.
VEGF (Vascular Endothelial Growth Factor) is the protein tumours use to grow new blood vessels. Without it, solid tumours cannot grow beyond 2mm. Dr. Hawa ZE Jaafar’s UPM research documenting VEGF downregulation puts Kacip Fatimah in serious oncology research territory — not supplement marketing.
It is endangered — and Malaysia’s leading researcher has a cultivation solution that increases phytochemicals by up to 1,000%. The supply crisis is solvable.
Like Tongkat Ali, Kacip Fatimah is over-harvested from the wild because commercial demand preceded cultivation infrastructure. Dr. Hawa ZE Jaafar’s CO₂ enrichment technique at UPM reduces the 16–18 month harvest cycle to 7–8 months while massively increasing compound concentration. The solution exists — it needs scaling.
Three Varieties. One Gets Almost All the Research.
Kacip Fatimah is a small, slow-growing forest floor herb — not a tree, not a shrub, but a low-growing perennial with long, slightly wavy leaves that lives in the shade of the Malaysian rainforest canopy. Three varieties are commercially recognised. They are not pharmacologically equivalent.
The winged petiole variety. Most clinical evidence for cardiovascular protection, hormonal modulation, vasorelaxant effects, and postmenopausal support derives from this variety. If purchasing, specify var. alata.
The smaller-leafed variety. Used in traditional preparations alongside var. alata. Part of the documented estrogenic and androgenic activities confirmed by IMR Malaysia. Less studied but traditionally significant.
The lance-shaped leaf variety. Phytochemical profile documented. Clinical research significantly more limited than the other two varieties. Traditionally used but modern evidence base is thin.
What Generations Called It — and What the Names Tell Us
Kacip = betel nut cutter. Something that prepares and eases. Named for what it does. First documented by Burkill (1935) — but the use predates that record by generations.
Selusuh = easing the passage. Used to prepare the uterus for birth and facilitate delivery. The name describes the application precisely — uterine toning, birth canal preparation, postpartum restoration.
Used by Orang Asli communities and across rural Malay villages. Also known as Akar Fatimah, Kunci Fatimah, Rumput Fatimah across different regions — the same plant, different communities, same applications.
Family Myrsinaceae. Endemic to Malaysia and Southeast Asian rainforests. Listed as vulnerable due to over-harvesting. Slow-growing: 16–18 months to harvestable size under normal conditions.
102 Compounds — Six That Drive the Story
A 2025 comprehensive PubMed review identified 102 chemical components from different parts of the plant. This is not a herb with one active ingredient. It is a matrix of interacting compounds — which is exactly why the traditional water decoction may outperform the capsule extract.
Gallic Acid
Found in leaves and roots. One of two primary biomarker compounds identified in the 2021 PMC vasorelaxant study. Documented antihypertensive and endothelium-dependent vasorelaxant properties. Present in the water extract — the traditional decoction form.
Catechin
Found in leaves and roots. The second primary biomarker compound for vasorelaxation. Works synergistically with gallic acid through endothelium-dependent mechanisms involving nitric oxide and calcium channel modulation — the same pathways targeted by pharmaceutical antihypertensives.
Phytoestrogens (Benzoquinones & Alkyls)
Bind to estrogen receptors with significantly lower affinity than human estrogen — modulating rather than replacing. In deficiency states: compensatory supplementation. In adequacy states: non-additive. IMR (2002) confirmed both estrogenic and androgenic activities.
Flavonoids & Phenolic Acids
Anti-inflammatory, antioxidant, and antimicrobial. The backbone of the plant’s anti-cancer and hepatoprotective activity confirmed by Dr. Hawa ZE Jaafar’s UPM research. CO₂ enrichment increases these compounds by 180–1,000%.
Saponins
Found primarily in roots. Contribute antimicrobial, anti-inflammatory, and adaptogenic effects. Saponins also function as carrier compounds for other bioactive constituents — lost in many commercial extraction processes that target specific fractions only.
β-Carotene & Ascorbic Acid
Found in leaves. Cellular defence antioxidants that contribute to the plant’s documented anti-aging and skin collagen synthesis-promoting properties. Support the broader phytochemical matrix rather than driving a single mechanism.
Three Studies That Reframe the Category
When “Women’s Herb” Produces Cardiovascular Mechanisms
The PMC 2021 study tested the water fraction of Labisia pumila on spontaneously hypertensive rat aortic ring preparations — the gold standard pre-clinical model for blood pressure research. The result: significant vasorelaxation through endothelium-dependent mechanisms. The biomarkers identified: gallic acid and catechin.
The mechanisms are specifically: nitric oxide production (endothelium-dependent vasodilation) and calcium channel modulation (direct smooth muscle relaxation). These are the two primary mechanisms of pharmaceutical antihypertensive drug classes — ACE inhibitors work upstream of nitric oxide; calcium channel blockers work directly on the channel. Kacip Fatimah engages both pathways.
A second study examined the aortic wall architecture directly. Ovariectomised rats treated with Labisia pumila water extract maintained elastic lamellae comparable to non-operated normal rats. The control group (untreated ovariectomised) showed expected arterial wall degradation. This architectural protection is one of the most fundamental cardiovascular benefits a compound can produce — it addresses the structural basis of arterial stiffness and hypertension.
PMC 2021 — Water fraction of Labisia pumila: vasorelaxant effects in hypertensive rat aortic rings. Biomarkers: gallic acid, catechin.
Six Months. 63 Women. Randomised, Double-Blind, Placebo-Controlled.
A six-month randomised, double-blind, placebo-controlled trial enrolled 63 postmenopausal women. The treatment group received 280mg/day of Labisia pumila water extract. The control group received placebo.
Result: significantly lower triglycerides in the Kacip Fatimah group compared to placebo — 1.4 mmol/L vs 1.9 mmol/L. Postmenopausal triglyceride elevation is a cardiovascular risk factor associated with oestrogen decline. The reduction is clinically meaningful and directly validates the cardiovascular research in a human trial.
This is a properly designed human clinical trial — not an animal study, not a traditional use claim. Six months, double-blind, placebo-controlled, postmenopausal women, water extract (the traditional preparation form). The trial was not powered to show blood pressure changes definitively, but the lipid findings stand as peer-reviewed human evidence for cardiovascular benefit.
6-month RCT — 63 postmenopausal women, 280mg/day water extract. Triglycerides: 1.4 vs 1.9 mmol/L (treatment vs placebo).
VEGF Suppression: From “Women’s Tonic” to Oncology Research
A 2018 study documented significant suppression of microvessel outgrowth through downregulation of VEGF — Vascular Endothelial Growth Factor. VEGF is the protein that tumours require to form new blood vessels for growth (angiogenesis). Without functional angiogenesis, solid tumours cannot grow beyond approximately 2mm.
Dr. Hawa ZE Jaafar at Universiti Putra Malaysia has spent more than five years researching Kacip Fatimah’s anti-cancer and chemo-protective properties. Her published work confirmed anti-cancer, anti-fungal, and anti-inflammatory activity alongside the phytoestrogenic profile. Her current investigations include Kacip Fatimah’s ability to protect cells during chemotherapy and reduce chemo-toxicity in patients undergoing treatment.
Dr. Jaafar also won the Silver Medal at the Malaysia Technology Expo for her CO₂ enrichment cultivation innovation — which simultaneously solves the supply crisis (reducing harvest time from 16–18 months to 7–8 months) and maximises therapeutic potency (increasing phytochemical content by 180–1,000%). The research is not marginal. The researcher is award-winning. The plant is being systematically underestimated.
2018 VEGF suppression study. Dr. Hawa ZE Jaafar, UPM — Anti-cancer and chemo-protection research programme. CO₂ enrichment cultivation: Silver Medal, Malaysia Technology Expo.
Sofia’s Story: Why the Preparation Method Is Not a Detail
My wife Sofia is from Miri, Sarawak. After her blood pressure began rising following her pregnancy, she added Kacip Fatimah to her protocol. She tried commercial capsules first. The results were modest. I then prepared the traditional concoction — dried leaves, dried roots, slow-cooked in water overnight. The results were different.
This is not unusual. The capsule form contains a fraction. The traditional concoction draws the full phytochemical matrix — including the gallic acid and catechin identified in the vasorelaxant research, the saponin carrier compounds, the prebiotic fibres that modulate gut microbiota and affect compound bioavailability. What the body responds to is not the label. It is the biochemistry.
Kacip Fatimah is not unique to Peninsula Malaysia. It is part of Borneo’s pharmacopoeia — Sarawak and Sabah communities have traditional use records as deep as the Peninsula Malay tradition. The marketing has centred the Peninsula experience. The plant belongs to the entire Malaysian rainforest ecosystem.
The broader wrong default: Malaysia has a plant with vasorelaxant, VEGF-suppressive, bone-protective, and hormonal regulatory properties — growing in its own rainforest — that is being sold internationally as a generic “women’s supplement,” losing most of its pharmacological significance in the translation.
From Rainforest Floor to Clinical Trial
Traditional Use Established
Malay women and Orang Asli communities develop systematic knowledge of Kacip Fatimah for prepartum preparation, birth facilitation, and postpartum recovery. The plant is named for what it does: Selusuh Fatimah — easing the passage.
First Western Documentation
Burkill documents Kacip Fatimah in the scientific literature. His record captures traditional applications that already reflect generations of systematic empirical observation — not recent discovery, but ancient knowledge entering the scientific record.
IMR Confirms Both Estrogenic AND Androgenic Activity
Malaysia’s Institute for Medical Research documents both estrogenic and androgenic activities in Labisia pumila. The plant the market calls a “women’s herb” is confirmed to have activity relevant to both sexes’ hormonal systems.
Journal of Food Research — Broad Biological Activity Review
Nik Hussain & Kadir (USM) publish: “Kacip Fatimah has wide range of biological activities including antioxidant, anti-inflammatory, antimicrobial, antifungal and antinociceptive properties. It has potential in the prevention and treatment of chronic diseases.”
Nutrients Journal — Bone Oxidative Protection
Research published in Nutrients demonstrates time- and dose-dependent improvement in bone oxidative status in postmenopausal osteoporosis rat model. Kacip Fatimah joins Tongkat Ali as a documented bone-protective herb — from complementary hormonal and structural angles.
VEGF Suppression Study
Significant suppression of microvessel outgrowth through VEGF downregulation documented. Kacip Fatimah enters active oncology research as a potential anti-angiogenic compound — the same mechanism class targeted by major cancer therapies such as bevacizumab.
PMC Vasorelaxant Study Published
Water fraction of Labisia pumila produces significant vasorelaxation in spontaneously hypertensive rat aortic rings through endothelium-dependent mechanisms. Biomarker compounds identified: gallic acid and catechin. Mechanisms: nitric oxide production, calcium channel modulation.
102 Compounds Confirmed
Comprehensive PubMed review identifies 102 chemical components from different parts of the plant. The pharmacological sophistication of the whole-plant matrix is confirmed — validating the traditional whole-plant water decoction over single-compound extracts.
Six Claims. Six Verdicts.
“Kacip Fatimah is a women’s herb — men have no use for it.”
Malaysia’s Institute for Medical Research (2002) documented both estrogenic and androgenic activities. The phytoestrogens in Kacip Fatimah bind to estrogen receptors with significantly lower affinity than human estrogen — meaning they modulate rather than overwhelm. The cardiovascular mechanisms (vasorelaxation, arterial wall protection, triglyceride reduction) are sex-neutral. The marketing is gendered. The plant is not.
“The capsule form is as effective as the traditional concoction.”
The vasorelaxant research identified gallic acid and catechin specifically in the water fraction — the traditional decoction. Many commercial capsules use different extraction solvents that may not capture these compounds equivalently. The saponins that carry other bioactives are also often lost in extraction. The 6-month human clinical trial that demonstrated triglyceride reduction used a water extract specifically. Standardised capsules have dosing advantages. Whole-plant water decoctions may have pharmacological completeness advantages. They are not equivalent.
“Kacip Fatimah is safe to use during pregnancy because it’s traditional.”
The traditional use for pregnancy was highly specific: pre-labour uterine toning in the final weeks, conducted under experienced guidance. This is categorically different from general pregnancy supplementation. Kacip Fatimah has uterine-stimulating properties — the same properties that make it useful for birth preparation make it potentially contraindicated in early and mid-pregnancy. “Traditional herb” does not equal “safe in all contexts.” Consult a healthcare provider before use during any stage of pregnancy.
“Kacip Fatimah has no cardiovascular research — it’s purely a hormonal supplement.”
The vasorelaxant research (PMC 2021), arterial wall architecture study (aorta elastic lamellae maintained comparable to normal rats), and the 6-month human RCT demonstrating triglyceride reduction (1.4 vs 1.9 mmol/L) are all published cardiovascular research. The mechanisms — nitric oxide production, calcium channel modulation, arterial structural protection — are the same mechanisms pharmaceutical antihypertensives are designed to target. The cardiovascular research exists. It simply is not in the marketing materials.
“Phytoestrogens from Kacip Fatimah will increase cancer risk.”
Kacip Fatimah’s phytoestrogens bind to estrogen receptors with significantly lower affinity than human estrogen — they modulate the receptor without the full stimulation that excess endogenous estrogen provides. The research shows the opposite of cancer promotion: VEGF suppression (anti-angiogenic), anti-cancer properties confirmed by Dr. Hawa ZE Jaafar’s UPM programme, and chemo-protective activity being investigated. The nuance: women with estrogen-sensitive cancers should still discuss any phytoestrogenic supplement with their oncologist.
“All Kacip Fatimah products on the market are essentially the same.”
Three varieties (var. alata, pumila, lanceolata) have different phytochemical profiles and radically different evidence bases — var. alata holds most of the cardiovascular and hormonal research. Different extraction methods capture different compound profiles — water extracts capture gallic acid and catechin; other solvents may not. Wild-harvested vs cultivated plants have different compound concentrations. Dr. Hawa ZE Jaafar’s CO₂ enrichment technique increases phytochemicals by 180–1,000% over conventional cultivation. Variety, extraction method, and cultivation method all matter enormously.
How to Use Kacip Fatimah
The traditional water decoction captures gallic acid and catechin — the vasorelaxant biomarkers — most completely. Capsules offer convenience and standardised dosing. Not all preparations are pharmacologically equivalent.
Method: Combine dried leaves and dried roots (var. alata where possible). Slow-cook in water for 4–8 hours or use a slow cooker overnight. Strain and consume the liquid.
Additions: Dates (kurma) or honey may be added. Some preparations include other herbs such as Tongkat Ali (male protocol) or dried ginger.
Rationale: Water extraction captures gallic acid, catechin, and saponins most completely — the compounds most relevant to cardiovascular and phytoestrogenic mechanisms.
Method: Commercial capsules or tablets.
Dose guide: 280–400mg water extract equivalent daily (based on clinical trial dosing). Confirm the variety is var. alata and that extraction method is specified.
Note: Convenient and consistent dosing. May not capture full compound matrix. Check extraction solvent on label — water or hydroalcoholic extraction preferred over petroleum-ether-based.
Method: Dried leaves and roots prepared as tea or mixed with warm water.
Dose guide: 3–5g dried herb per cup, steeped 10–15 minutes.
Note: Midpoint between traditional decoction and capsule. More convenient than slow-cooking, captures more compounds than encapsulated powder of the same herb.
Method: Combined with other traditional herbs in the jamu preparation tradition — often Tongkat Ali, halia (ginger), and other complementary herbs.
Rationale: Traditional preparations were rarely single-herb. The synergistic combination reflects generations of empirical refinement. Compound interactions between herbs may produce effects not seen in single-herb preparations.
Most cardiovascular research is animal-model: The vasorelaxant and arterial architecture studies use rat models. The 6-month human RCT demonstrated triglyceride reduction but was not powered to show blood pressure changes definitively. Large-scale human trials for blood pressure outcomes are not yet published.
Anti-cancer research is preliminary: VEGF suppression and chemo-protection mechanisms are compelling — Dr. Hawa ZE Jaafar’s programme is ongoing and award-winning. But clinical human anti-cancer evidence is not yet available. This is mechanistic and pre-clinical research, not established oncology treatment.
Uterine effects require caution: Traditional use for pre-labour preparation is specific. General pregnancy use without guidance is inappropriate. Women with estrogen-sensitive conditions should consult their healthcare provider.
Variety and extraction matter: Not all Kacip Fatimah products are equivalent. Var. alata with water extraction captures the compounds most relevant to the published clinical evidence. Generic products of unknown variety and extraction method may not deliver the same pharmacological profile.
The research base is growing but incomplete: Kacip Fatimah deserves the scale of research investment given to Tongkat Ali. It has not yet received it. The 102 compounds are identified — their interactions are not fully mapped.
References & Sources ↓
- PMC 2021 — Water fraction of Labisia pumila: vasorelaxant effects in spontaneously hypertensive rat aortic ring preparations. Biomarkers: gallic acid and catechin. Mechanisms: nitric oxide, calcium channel modulation.
- 6-month RCT — 63 postmenopausal women, 280mg/day water extract, randomised double-blind placebo-controlled. Triglycerides: 1.4 vs 1.9 mmol/L treatment vs placebo.
- 2025 PubMed comprehensive review — 102 chemical components identified from Labisia pumila.
- IMR Malaysia (2002) — Both estrogenic and androgenic activities documented in Labisia pumila.
- Nik Hussain & Kadir (2013). Journal of Food Research, USM — Broad biological activities: antioxidant, anti-inflammatory, antimicrobial, antifungal, antinociceptive.
- Nutrients (2014) — Time- and dose-dependent effects on bone oxidative status in postmenopausal osteoporosis rat model.
- 2018 VEGF suppression study — Significant suppression of microvessel outgrowth through VEGF downregulation.
- Dr. Hawa ZE Jaafar, UPM — Anti-cancer, anti-fungal, anti-inflammatory, chemo-protection research programme. CO₂ enrichment cultivation technique: Silver Medal, Malaysia Technology Expo.
- Burkill (1935) — First Western scientific documentation of Kacip Fatimah / Labisia pumila traditional uses.
- Aorta study — Water extract of Labisia pumila maintains elastic lamellae architecture in ovariectomised rats comparable to non-operated normal rats.